Literature DB >> 30065019

Unproven value of end-of-treatment and serial follow-up FDG-PET in primary mediastinal B-cell lymphoma.

Hugo J A Adams1, Thomas C Kwee2.   

Abstract

Keywords:  bone marrow microenvironment; hematopoiesis; hematopoietic stem cell; stem cell transplantation

Mesh：

Substances：

Year:  2018        PMID： 30065019      PMCID： PMC6068017          DOI： 10.3324/haematol.2018.198523

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  10 in total

1.  Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R.

Authors:  Lisa Giulino-Roth; Tara O'Donohue; Zhengming Chen; Nancy L Bartlett; Ann LaCasce; William Martin-Doyle; Matthew J Barth; Kimberly Davies; Kristie A Blum; Beth Christian; Carla Casulo; Sonali M Smith; James Godfrey; Amanda Termuhlen; Matthew J Oberley; Sarah Alexander; Sheila Weitzman; Burton Appel; Benjamin Mizukawa; Jakub Svoboda; Zeinab Afify; Melinda Pauly; Hema Dave; Rebecca Gardner; Deborah M Stephens; William A Zeitler; Christopher Forlenza; Jennifer Levine; Michael E Williams; Jody L Sima; Catherine M Bollard; John P Leonard
Journal:  Br J Haematol       Date:  2017-10-29       Impact factor: 6.998

2.  Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07).

Authors:  Christoph Mamot; Dirk Klingbiel; Felicitas Hitz; Christoph Renner; Thomas Pabst; Christoph Driessen; Ulrich Mey; Miklos Pless; Mario Bargetzi; Fatime Krasniqi; Federica Gigli; Thomas Hany; Andrei Samarin; Christine Biaggi; Corinne Rusterholz; Stephan Dirnhofer; Emanuele Zucca; Giovanni Martinelli
Journal:  J Clin Oncol       Date:  2015-07-06       Impact factor: 44.544

3.  Favorable outcome of primary mediastinal large B-cell lymphoma patients treated with sequential RCHOP-RICE regimen without radiotherapy.

Authors:  Neta Goldschmidt; Geffen Kleinstern; Marina Orevi; Ora Paltiel; Dina Ben-Yehuda; Alex Gural; Diana Libster; David Lavie; Moshe E Gatt
Journal:  Cancer Chemother Pharmacol       Date:  2016-04-07       Impact factor: 3.333

4.  PET/CT in primary mediastinal large B-cell lymphoma responding to rituximab-CHOP: An analysis of 106 patients regarding prognostic significance and implications for subsequent radiotherapy.

Authors:  T P Vassilakopoulos; G A Pangalis; S Chatziioannou; S Papageorgiou; M K Angelopoulou; Z Galani; G Kourti; V Prassopoulos; T Leonidopoulou; E Terpos; M N Dimopoulou; S Sachanas; C Kalpadakis; P Konstantinidou; D Boutsis; E Stefanoudaki; L Kyriazopoulou; M P Siakantaris; M-C Kyrtsonis; E Variami; I Kotsianidis; A Symeonidis; E Michali; E Katodritou; G Kokkini; C Tsatalas; H Papadaki; M-A Dimopoulos; V Sotiropoulos; V Pappa; T Karmiris; J Meletis; J Apostolidis; I Datseris; P Panayiotidis; K Konstantopoulos; P Roussou; P Rondogianni
Journal:  Leukemia       Date:  2015-05-14       Impact factor: 11.528

Review 5.  Prognostic value of complete remission status at end-of-treatment FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma: systematic review and meta-analysis.

Authors:  Hugo J A Adams; Rutger A J Nievelstein; Thomas C Kwee
Journal:  Br J Haematol       Date:  2015-04-01       Impact factor: 6.998

6.  Limited utility of surveillance imaging for detecting disease relapse in patients with non-Hodgkin lymphoma in first complete remission.

Authors:  Quoc Truong; Nilay Shah; Mark Knestrick; Brendan Curley; Yanqing Hu; Michael Craig; Mehdi Hamadani
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2013-10-10

7.  Routine Imaging for Diffuse Large B-Cell Lymphoma in First Complete Remission Does Not Improve Post-Treatment Survival: A Danish-Swedish Population-Based Study.

Authors:  Tarec Christoffer El-Galaly; Lasse Hjort Jakobsen; Martin Hutchings; Peter de Nully Brown; Herman Nilsson-Ehle; Elisabeth Székely; Karen Juul Mylam; Viktoria Hjalmar; Hans Erik Johnsen; Martin Bøgsted; Mats Jerkeman
Journal:  J Clin Oncol       Date:  2015-10-05       Impact factor: 44.544

8.  Delineating outcomes of patients with diffuse large b cell lymphoma using the national comprehensive cancer network-international prognostic index and positron emission tomography-defined remission status; a population-based analysis.

Authors:  Mark J Bishton; Simon Hughes; Faith Richardson; Eleanor James; Eric Bessell; Vishakha Sovani; Rakesh Ganatra; Andrew P Haynes; Andrew K McMillan; Christopher P Fox
Journal:  Br J Haematol       Date:  2015-11-18       Impact factor: 6.998

9.  No survival benefit associated with routine surveillance imaging for Hodgkin lymphoma in first remission: a Danish-Swedish population-based observational study.

Authors:  Lasse H Jakobsen; Martin Hutchings; Peter de Nully Brown; Johan Linderoth; Karen J Mylam; Daniel Molin; Hans E Johnsen; Martin Bøgsted; Mats Jerkeman; Tarec C El-Galaly
Journal:  Br J Haematol       Date:  2016-02-05       Impact factor: 6.998

10.  End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making.

Authors:  Christopher Melani; Ranjana Advani; Mark Roschewski; Kelsey M Walters; Clara C Chen; Lucia Baratto; Mark A Ahlman; Milos D Miljkovic; Seth M Steinberg; Jessica Lam; Margaret Shovlin; Kieron Dunleavy; Stefania Pittaluga; Elaine S Jaffe; Wyndham H Wilson
Journal:  Haematologica       Date:  2018-05-10       Impact factor: 9.941
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.